Sign in
CEROW Stock Price, Chart, Stats & News
CERo Therapeutics Holdings Inc
Save
CERo Therapeutics Holdings Inc (CEROW) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
CEROW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -19.65% |
Operating margin | -1310.19% |
Pretax margin | -1215.62% |
Net margin | -1215.60% |
Effective tax rate | – |
ROA | -361.39% |
ROE | 673.03% |
D/E | -0.20x |
Interest coverage ratio | 572.62x |
CEROW valuation
P/E | – |
P/S | 0.03x |
P/B | -0.01x |
P/CF | -0.01x |
P/FCF | -0.00x |
P/OCF | -0.01x |
PEG | -0.00x |
EV multiple | -0.09x |
About
CERo Therapeutics Holdings, Inc. operates as an immunotherapy firm, concentrating its efforts on developing cutting-edge engineered T-cell therapies designed to combat cancer. Its primary therapeutic initiative addresses blood cancers, specifically by aiming to counteract a particular "Eat Me" signaling mechanism that is significantly overexpressed on both B-cell and myeloid tumor cells. The company's corporate headquarters are situated in South San Francisco, California.
Similar securities
Based on sector and market capitalization
Report issue